Door-to-Balloon Delays with PCI in Acute Myocardial Infarction

Daniel R. Guerra1, C. Michael Gibson

  • 1TIMI Data Coordinating Center and Angiographic Core Laboratory, 350 Longwood Avenue, First Floor, Boston, MA 02115, USA. mgibson@perfuse.org

Insights

Reducing door-to-balloon time is critical for improving outcomes in acute myocardial infarction (AMI) patients undergoing primary percutaneous transluminal coronary angioplasty (PTCA). Faster revascularization maximizes the benefits of PTCA and reduces mortality risks.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Emergency Medicine

Background:

  • Timely revascularization is key in acute myocardial infarction (AMI) treatment.
  • Primary percutaneous transluminal coronary angioplasty (PTCA) offers superior outcomes compared to thrombolysis.
  • Primary PTCA can lead to longer door-to-balloon times.

Purpose of the Study:

  • To emphasize the critical importance of minimizing door-to-balloon time in AMI treatment.
  • To highlight the negative impact of delays on primary PTCA efficacy.
  • To advocate for streamlined protocols to improve patient outcomes.

Main Methods:

  • Review of clinical data and established treatment protocols for AMI.
  • Analysis of the relationship between door-to-balloon time and patient outcomes.
  • Emphasis on institutional performance assessment.

Main Results:

  • Increased door-to-balloon time diminishes the benefits of primary PTCA.
  • Shorter delays correlate with improved infarct-related artery patency and reduced mortality.
  • Protocols and performance monitoring are essential for reducing delays.

Conclusions:

  • Institutions offering PTCA must prioritize reducing door-to-balloon times.
  • Implementing established protocols and continuous performance assessment are vital.
  • Minimizing delays enhances the effectiveness of primary PTCA in AMI management.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...